Bausch + Lomb said on Friday it would acquire several Novartis eye-care products for $1.75 billion as their market grows.
You are here: Home / Bausch + Lomb buys Novartis drugs for $1.75 billion to boost eye-care portfolio
Market News and Views
Bausch + Lomb said on Friday it would acquire several Novartis eye-care products for $1.75 billion as their market grows.